Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Ellen_Donnelly
|
| gptkbp:country |
gptkb:Sweden
|
| gptkbp:focus |
mitochondrial medicine
|
| gptkbp:formerName |
gptkb:Abliva_AB
|
| gptkbp:founded |
2000
|
| gptkbp:headquarters_location |
gptkb:Lund
|
| https://www.w3.org/2000/01/rdf-schema#label |
NeuroVive Pharmaceutical AB
|
| gptkbp:industry |
gptkb:biotechnology
pharmaceuticals |
| gptkbp:product_development |
treatments for mitochondrial diseases
|
| gptkbp:stockExchange |
gptkb:Nasdaq_Stockholm
|
| gptkbp:stockSymbol |
gptkb:NVP
|
| gptkbp:website |
https://www.abliva.com/
|
| gptkbp:bfsParent |
gptkb:Abliva
|
| gptkbp:bfsLayer |
7
|